Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide.
about
Staphylococcus aureus cap5O and cap5P genes functionally complement mutations affecting enterobacterial common-antigen biosynthesis in Escherichia coliMammary Gland Pathology Subsequent to Acute Infection with Strong versus Weak Biofilm Forming Staphylococcus aureus Bovine Mastitis Isolates: A Pilot Study Using Non-Invasive Mouse Mastitis Model.Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence.Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin.Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides.Genetic and serologic evaluation of capsule production by bovine mammary isolates of Staphylococcus aureus and other Staphylococcus spp. from Europe and the United States.Promoter analysis of the cap8 operon, involved in type 8 capsular polysaccharide production in Staphylococcus aureus.Functional analysis of the Staphylococcus aureus collagen adhesin B domainMolecular characterization of Streptococcus pneumoniae type 4, 6B, 8, and 18C capsular polysaccharide gene clustersThe capsular polysaccharide of Staphylococcus aureus is attached to peptidoglycan by the LytR-CpsA-Psr (LCP) family of enzymesLaboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein AMucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor.Effects of culture conditions on production of type 5 capsular polysaccharide by human and bovine Staphylococcus aureus strainsA Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.Cloning of type 8 capsule genes and analysis of gene clusters for the production of different capsular polysaccharides in Staphylococcus aureus.Molecular characterization and transcriptional analysis of type 8 capsule genes in Staphylococcus aureusStaphylococcus aureus capsular polysaccharides.Surface Glycopolymers Are Crucial for In Vitro Anti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus.Positive correlation between tyrosine phosphorylation of CpsD and capsular polysaccharide production in Streptococcus pneumoniae.Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A.Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates.Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytesChemical characterization and immunogenicity of capsular polysaccharide isolated from mucoid Staphylococcus aureus.Reactivity of type-specific monoclonal antibodies with Staphylococcus aureus clinical isolates and purified capsular polysaccharide.Type 5 and 8 capsular polysaccharides are expressed by Staphylococcus aureus isolates from rabbits, poultry, pigs, and horses.Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8.Prevalence of capsular polysaccharide types 5 and 8 among Staphylococcus aureus isolates from cow, goat, and ewe milkStaphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosisDirect testing of blood culture for detection of the serotype 5 and 8 capsular polysaccharides of Staphylococcus aureusPhagocytosis of mastitis isolates of Staphylococcus aureus and expression of type 5 capsular polysaccharide are influenced by growth in the presence of milk.Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus.Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types.Reactivity of coagulase-negative staphylococci isolated from cow and goat milk with monoclonal antibodies to Staphylococcus aureus capsular polysaccharide types 5 and 8.Encapsulation of Staphylococcus aureus isolates from mastitic milk: relationship between capsular polysaccharide types 5 and 8 and colony morphology in serum-soft agar, clumping factor, teichoic acid, and protein A.Antiserum agar method for identification of Smith type exopolysaccharides in clinical isolates of Staphylococcus aureusPlatelet aggregation induced by serotype polysaccharides from Streptococcus mutans.Synthesis of microcapsule by Staphylococcus aureus is not responsive to environmental phosphate concentrations.Antigenic determinants of Staphylococcus aureus type 5 and type 8 capsular polysaccharide vaccines.Distribution of capsular materials on the cell wall surface of strain Smith diffuse of Staphylococcus aureus.Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships.
P2860
Q24520553-B95AC1DE-BB63-4949-AF55-FFC9557F7CFFQ30364039-2F61DD86-4DEB-4BC4-A600-40EB3BDF75B0Q33788238-5A541B3E-3C69-46A8-820E-9F8EBF75B1D5Q33795274-D0D72787-20CA-423B-BB09-633028859BA1Q33931083-F8C0273F-D869-483A-B162-73FC65B133D1Q33968870-7B3B865D-E891-4FFC-9948-FA73E86859D1Q33991770-D790F738-01D7-4026-9E2A-78D8C1CC5062Q34001400-C694F08D-FD1C-42E3-98C6-27706D069C27Q34006164-10F1B42E-B275-4C2F-9875-7BBA07B29615Q34076020-A9F7AC2D-FC58-4350-BCF2-BD16755DD188Q34526987-922155D4-21AF-4141-9EB1-B417E2014307Q35090848-5A73DD80-1738-40CC-9520-F48A561F9A11Q35224198-E08FD89D-B7C9-4B17-90BD-560CCA7D51C7Q35489404-E40B799C-A436-4BD1-BC45-CC89AAE02880Q35605034-9368FDDC-134B-4375-A539-7916504CC026Q35620548-C944D50E-9D3E-4B37-A831-7EBBE5D1A63DQ35630504-A9329D03-284A-4055-9B43-77C50E060435Q36138021-82A929CC-E8D3-44B3-ADEC-2D8C9FEBFFE7Q36474326-9B1F544A-1EA9-433F-BA90-DE1F8840E675Q36985988-468F4B2D-5BBF-4B4A-91F0-854A8FA10838Q36998805-975E204B-570B-4FFB-8287-D7D4AC3C3CFDQ37003768-E8BBAA81-FA03-47A8-92CE-1001449C4A99Q37022737-9BD620E0-93E8-4857-BD15-31605FB6EAEDQ37050644-64C2C976-5CFA-4A98-BE07-7F639BE4DBBBQ37064940-4A28193B-B759-42C0-92E4-904E4478BFBFQ37138114-405B054D-A704-4056-8360-137774B098D8Q37141881-B6765E0E-7BD6-41E1-9F07-95050BD408A7Q37158972-F8A3DC16-CFB1-4473-BFF3-845BBF3B4FFBQ37173156-3B3674F4-DA8D-4557-8204-B96562BFC074Q37190859-2C3CDB7B-EF98-4296-ADDB-98A297C33844Q37197631-75FC45AC-FA58-4482-A427-013F90DB8BDBQ37200307-4427918B-8728-4C88-8BE6-24DA48354F40Q37226710-A33C7EB9-10C1-478A-9E70-78D780BED892Q37227598-AF60F70E-8DC6-402F-BD74-EC6E103D34A5Q37278648-08D273E3-60CF-4756-8FF2-453CAEFF8B68Q37427087-7FE89C38-F7AD-4A8A-AE88-7E255C410190Q39572650-F8665DB9-5D04-4AC4-9F71-1BF7A6311BA4Q39573071-71BEE6D4-D9B7-40A2-8173-4F615D114E8FQ39942308-4BB3F0E9-5594-45D3-A534-C7D8E577F317Q40174122-9BA6292F-40B2-4B1E-9FF5-1700E11841C1
P2860
Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1984
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Purification and characterizat ...... ype 8 capsular polysaccharide.
@en
Purification and characterizat ...... ype 8 capsular polysaccharide.
@nl
type
label
Purification and characterizat ...... ype 8 capsular polysaccharide.
@en
Purification and characterizat ...... ype 8 capsular polysaccharide.
@nl
prefLabel
Purification and characterizat ...... ype 8 capsular polysaccharide.
@en
Purification and characterizat ...... ype 8 capsular polysaccharide.
@nl
P2093
P2860
P1476
Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide
@en
P2093
P2860
P407
P577
1984-07-01T00:00:00Z